Navigation Links
The Michael J. Fox Foundation Announces Fourth Quarter Participants in Partnering Program Between Awardees and Industry
Date:11/15/2012

NEW YORK, Nov. 15, 2012 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation (MJFF) has announced fourth-quarter 2012 participants in its Partnering Program. Selected from the most promising research projects in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By connecting industry leaders with those projects ripe for investment, the Foundation aims to drive forward promising projects in PD research through the pipeline of drug development, and eventually into patients' hands.

Non-confidential overviews of select MJFF-funded projects are shared with industry contacts and more broadly via MJFF's Web site on a quarterly basis.

MJFF-supported projects featured in Q4 include:

  • SynAgile is developing DopaFuse, a levodopa prodrug which is continuously, subcutaneously infused using a simple insulin infusion pump.  It is designed to reduce motor fluctuations in people with PD.
  • Durin Technologies has completed work to determine if using specific autoantibodies as diagnostic biomarkers for full-blown Parkinson's could also be used for early detection of PD.
  • Sapiens is working on technology to more accurately stimulate intended therapeutic brain structures in Deep Brain Stimulation, toward improving therapeutic outcomes and reducing side effects for Parkinson's patients. 

Overviews from awardees PsychoGenics and Gliacor Therapeutics were showcased in Q3 2012.

To date, the Foundation has funded over $304 million in research, over $81 million of which has been directed to more than 170 unique projects led by industry partners.

To view the Q4 2012 participants, and all MJFF awardees featured via the Partnering Program thus far, visit the Partnering Program page at https://www.michaeljfox.org/research/opportunities-for-industry/partnering-program.html.

To find out more, please contact the MJFF Research Partnerships team at ResearchPartnerships@michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
2. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
3. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
4. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
5. The Michael J. Fox Foundation Launches The $14 Million-Edmond J. Safra Core Programs for PD Research
6. Response to U.S. Supreme Courts Healthcare Decision by Michael Zamagias, Chairman, TeleTracking Technologies
7. Lilly Announces Retirement of Robert Armitage, Names Michael Harrington Senior Vice President and General Counsel
8. AMRI Appoints Michael Nolan Vice President, Chief Financial Officer and Treasurer
9. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
10. Michael Epstein joins MedSpan Research as Director, Research Services
11. American Academy of Family Physicians Foundation Launches Cities for Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):